Objective
To examine 1-year graft patency and intraoperative revision rates in patients undergoing CABG based on intraoperative TTF assessment (2738 grafts) from retrospective analysis of a multicenter randomized clinical trial conducted at 18 Veterans Affairs hospitals using the Randomized On/Off Bypass (ROOBY) Trial data set. study TTF probe data were analyzed of 1 or more grafts (total 2738 grafts) from 1607 patients of the original 2203 patients undergoing CABG surgery (with or without CPB) from 2/01/2002 to 5/31/2008. Examined were:
• Frequency of Flowprobe Use: 12 centers, most cases; 3 centers 1/3 of cases; 3 centers, sparingly or not at all.
• Intraoperative Flow and Pulsatility Index (PI) values;
• Intraoperative revision rates with prerevision and postrevision flow and PI values;
• 1-year graft patency rates for the 1710 (62.5%) grafts that underwent cardiac catheterization assessment.
• Sensitivity, specificity and positive and negative predictive values of using the transit time Flowprobe to predict graft patency.
criteria & threshOlds
• Single outlet grafts, sequential and T-grafts were excluded.
• Intraoperative flow values: <20 mL/min = low flow graft; ≥ 20 mL/min = normal flow graft.
• PI values: ≤3, 3-5, >5 compared due to literature ambiguity as to whether PI ≥ 3 or ≥ 5 is abnormal.
• Graft patency scored at 1 year by FitzGibbon classification system (Grade A: excellent; Grade O: occluded).
• The decision to revise a graft was left to the judgment of the attending surgeon
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cOnclusiOns Intraoperative TTF probe data may be helpful in predicting long-term patency and in the decision of whether to revise a questionable graft for patients undergoing CABG surgery.
transOnic ObservatiOns • PI, a questionable indicator at best of graft patency, was an unfortunate criterien of the study.
• The authors hesitated to recommend that transit time flow measurement be adopted as a standard of practice, but they do conclude that it may be helpful in deciding to revise a questionable graft. This is noteworthy given the number of authors and VA centers represented in the study. 
